FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreACR® joined a multisociety initiative opposing proposed Local Coverage Determinations (LCDs) that would significantly restrict Medicare coverage for peripheral nerve blocks and related procedures used to treat chronic pain.
These LCD policies threaten patient access to evidence-based, opioid-sparing treatments and contradict federal efforts to reduce opioid reliance.
ACR co-signed letters submitted by the Society of Interventional Radiology and the Multisociety Pain Workgroup to five Medicare Administrative Contractors, urging them to rescind the proposed LCDs.
“Restrictive LCDs risk undermining CMS’s opioid reduction goals by eliminating access to proven non-opioid therapies,” the letters state. The ACR Contractor Advisory Committee Network and the Commission on Interventional and Cardiovascular Imaging have reviewed the proposals and voiced opposition.
Key concerns include:
For more information, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more